0001354488-13-001071.txt : 20130308 0001354488-13-001071.hdr.sgml : 20130308 20130308133948 ACCESSION NUMBER: 0001354488-13-001071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130306 FILED AS OF DATE: 20130308 DATE AS OF CHANGE: 20130308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pernix Sleep, Inc. CENTRAL INDEX KEY: 0001339455 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200161599 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 440 STEVENS AVENUE, STREET 2: SUITE 200 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: (858) 876-6500 MAIL ADDRESS: STREET 1: 440 STEVENS AVENUE, STREET 2: SUITE 200 CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER COMPANY: FORMER CONFORMED NAME: Somaxon Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20050922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAST ERLE T CENTRAL INDEX KEY: 0001051411 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51665 FILM NUMBER: 13676370 MAIL ADDRESS: STREET 1: C/O SPIROS DEVELOPMENT CORP II INC STREET 2: 7475 LUSK BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 issuerdirect_section16.xml PRIMARY DOCUMENT X0306 4 2013-03-06 1 0001339455 Pernix Sleep, Inc. SOMX 0001051411 MAST ERLE T C/O SOMAXON PHARMACEUTICALS, INC. 440 STEVENS AVENUE, SUITE 200 SOLANA BEACH CA 92075 1 Common Stock 2013-03-06 4 D 0 39162 0 D 0 D These securities represent common stock and restricted stock units vested immediately prior to the effective time of the merger, all of which were disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated as of December 10, 2012 by and among Somaxon Pharmaceuticals, Inc., a Delaware corporation (?Somaxon?), Pernix Therapeutics Holdings, Inc. (?Pernix?) and Pernix Acquisition Corp. I, a Delaware corporation and a wholly owned subsidiary of Pernix, in exchange for Pernix common stock at an exchange ratio of 1 share of Somaxon common stock for 0.477730059 shares of Pernix common stock. /s/ Matthew W. Onaitis, Attorney-in-fact 2013-03-06